Adjustable vascular occlusion device assembly
Patent Information
- Application Number
- JP2023551801
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-02-25
- Filing Date
- 2022-02-24
- Publication Date
- 2025-06-02
- Estimated Expiration
- 2042-02-24
AI Technical Summary
Existing vascular closure devices (VCDs) face challenges in achieving rapid and effective hemostasis due to difficulties in properly orienting the sheath relative to the blood vessel, leading to increased insertion force, vessel trauma, and risk of accidental withdrawal of anchors.
A VCD assembly with a sheath having a beveled distal end and a rotatable housing that restrains axial displacement, allowing the sheath to be oriented in a bevel-down position for insertion and rotated to a bevel-up position post-insertion, ensuring the anchor is parallel to the vessel wall.
Facilitates easy insertion of the sheath into the blood vessel, reduces vessel trauma, and ensures the anchor is oriented correctly for effective hemostasis, thereby reducing the risk of accidental withdrawal and improving procedural efficiency.
Smart Images

Figure 00000014_0000 
Figure 00000015_0000 
Figure 00000016_0000
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This disclosure claims the benefit of and priority to U.S. Provisional Application No. 63 / 153,860, filed February 25, 2021, the disclosure of which is incorporated by reference in its entirety herein.
[0002] SUMMARY The present disclosure relates generally to a vascular closure device assembly that can be adjusted in situ to achieve a desired orientation. [Background technology]
[0003] Vascular trauma, such as arterial or venous trauma, can result in rapid blood loss and can be fatal unless vascular hemostasis, i.e., blood flow is rapidly stopped by closing and repairing the opening of the blood vessel through which blood is leaking, so that the cardiovascular system can resume its normal function of supplying blood to various parts of the body at normal blood pressure. Traditionally, hemostasis is achieved by applying pressure to the patient's body part on the patient's skin, which is not very effective at closing the opening and may take a relatively long time to achieve hemostasis, if achieved at all. Recently, vascular closure devices (VCDs) have been used to rapidly achieve hemostasis. Some VCDs include a sheath that is first inserted into the blood vessel where hemostasis is being achieved. Various components of the VCD are inserted toward or into the blood vessel through the sheath, and the sheath may serve to position the various components of the VCD relative to the blood vessel. Summary of the Invention
[0004] The embodiments described herein generally relate to systems and methods for obtaining a proper orientation of a sheath relative to a blood vessel. In particular, the embodiments described herein relate to a VCD assembly including a sheath having a beveled distal end and a proximal end secured to a housing, and a dilator that engages the sheath to move the sheath between a first configuration in which the beveled distal end is bisected and an axis extending through the tip of the beveled distal end is at an angle to the blood vessel such that the tip of the beveled distal end is inserted into the blood vessel, and a second configuration in which the housing constrains axial displacement of the sheath and the sheath is rotated such that the bisecting axis is substantially parallel to the blood vessel.
[0005] In some embodiments, a VCD assembly includes: a sheath having a sheath body defining a channel through the sheath body, a sheath engagement portion, and a sheath attachment portion located at a proximal end of the sheath body; a housing, where the sheath attachment portion is secured within the housing such that the sheath is rotatable relative to the housing and the housing constrains axial displacement of the sheath relative to the housing; and a dilator, where the dilator body has a dilator engagement portion extending from the dilator body toward the sheath, the dilator engagement portion configured to engage the sheath engagement portion such that axial displacement of the dilator relative to the sheath rotates the sheath relative to the housing, and the housing is configured to constrain axial displacement of the sheath during rotation.
[0006] In some embodiments, a method of operating a vascular closure device assembly having a sheath having a sheath body defining a beveled distal end and a sheath attachment portion located at a proximal end of the sheath body, a housing in which the sheath attachment portion is disposed, and a dilator through the housing to engage the sheath, the method comprising: inserting at least a portion of the dilator into the housing such that the dilator engages the sheath and moves the sheath to a first configuration in which the tip of the beveled distal end is located on a side corresponding to a side of the vessel in which the opening is located; inserting the sheath in the first configuration into a tissue track; inserting the tip of the beveled distal end of the sheath through a wall of the vessel and into the vessel; and axially displacing the dilator away from the housing such that the dilator engages the sheath and rotates the sheath relative to the housing to move the sheath to a second configuration in which the tip of the beveled distal end is located on a side opposite the side of the vessel in which the opening is located, the housing constraining axial displacement of the sheath relative to the housing.
[0007] It should be understood that all combinations of the foregoing concepts, and additional concepts discussed in more detail below, are contemplated as part of the subject matter disclosed herein (unless such concepts are mutually inconsistent). In particular, all combinations of subject matter recited in the claims appearing at the end of this disclosure are contemplated as part of the subject matter disclosed herein. [Brief description of the drawings]
[0008] The foregoing and other features of the present disclosure will become more fully apparent from the following description and appended claims, taken in conjunction with the accompanying drawings, in which the present disclosure is described with additional specificity and detail, with the understanding that these drawings depict only some implementations in accordance with the present disclosure and are therefore not to be considered limiting of its scope.
[0009] [Figure 1] 1 is a schematic block diagram of a VCD assembly according to one embodiment. [Diagram 2]1A-1D are front, right and bottom views of a VCD assembly according to another embodiment. [Diagram 3] FIG. 3 is an exploded view of the VCD assembly of FIG. 2. [Figure 4A] FIG. 3 is a right side view of a sheath included in the VCD assembly of FIG. 2. [Figure 4B] FIG. 3 is a left side view of a sheath included in the VCD assembly of FIG. 2. [Figure 5A] 3A-3C are front, right and bottom views of a housing included in the VCD assembly of FIG. 2 according to one embodiment. [Figure 5B] 5B is a cross-sectional view of the housing of FIG. 5A taken along line AA of FIG. 5A. [Figure 6] 5A-5B showing a sheath attachment portion of the sheath disposed on an attachment structure of the housing, according to one embodiment. FIG. [Figure 7] FIG. 3 is a front, left, top perspective view of an expander included in the VCD assembly of FIG. [Figure 8A] 3 is a front right perspective view of the VCD assembly of FIG. 2 in a first configuration. [Figure 8B] 8B is a cross-sectional view of a portion of the VCD assembly of FIG. 8A as indicated by arrow X in FIG. 8A. [Figure 8C] FIG. 8B is a side view of the beveled distal end of the sheath of the VCD assembly of FIG. 8A inserted into a blood vessel. [Figure 8D] FIG. 13 is a side view of the beveled distal end after insertion into a blood vessel. [Figure 9A] 3 is a front perspective view of the VCD assembly of FIG. 2 moved to a second configuration by displacing the expander away from the housing. FIG. [Figure 9B] 9B is a cross-sectional view of a portion of the VCD assembly of FIG. 9A as indicated by arrow Y in FIG. 9A. [Figure 9C] FIG. 13 is a side view of the orientation of the beveled distal end of the sheath within a vessel. [Figure 10A] 3 is a front perspective view of the VCD assembly of FIG. 2 in a second configuration. [Figure 10B]10B is a cross-sectional view of a portion of the VCD assembly of FIG. 10A as indicated by arrow Z in FIG. 10A. [Figure 10C] FIG. 13 is a side view of the orientation of the beveled distal end of the sheath within the vessel in a second configuration. [Figure 11] 3 is a side perspective view of the VCD assembly of FIG. 2 with the dilator removed from the assembly after moving the assembly to the second configuration. [Figure 12A] 3 is a side view of the beveled distal end of the sheath of the VCD assembly of FIG. 2 inserted into a blood vessel in a first orientation. [Figure 12B] FIG. 13 is a side view of the beveled distal end in a second configuration within a blood vessel. [Figure 12C] 13 is a side cross-sectional view of a sheath inserted through a tissue passage into a blood vessel with the beveled distal end in a second orientation and with an anchor extending from the beveled distal end. [Figure 13] 1 is a schematic flow chart of a method of inserting a sheath of a VCD device into a blood vessel to perform various endovascular procedures (eg, arteriotomy), according to one embodiment.
[0010] Reference is made to the accompanying drawings throughout the following detailed description. In the drawings, like symbols typically identify like components unless context dictates otherwise. The example implementations described in the detailed description, drawings, and claims are not meant to be limiting. Other implementations may be utilized, and other changes may be made, without departing from the spirit or scope of the subject matter presented herein. It is readily understood that the aspects of the present disclosure, as generally described herein and illustrated in the figures, can be arranged, substituted, combined, and designed in a wide variety of different configurations, all of which are expressly intended and made a part of this disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0011] The embodiments described herein generally relate to systems and methods for obtaining a proper orientation of a sheath relative to a blood vessel. In particular, the embodiments described herein relate to a VCD assembly including a sheath having an angled distal end and a proximal end secured to a housing, and a dilator engaged with the sheath to move the sheath between a first configuration in which an axis bisecting the angled distal end and extending through the tip of the angled distal end is oblique (at an angle) to the blood vessel such that the tip of the angled distal end is inserted into the blood vessel, and a second configuration in which the sheath rotates while the housing constrains axial displacement of the sheath such that the bisecting axis is substantially parallel to the blood vessel.
[0012] Some VCDs include a sheath that is first inserted into the vessel where hemostasis is being achieved. Various components of the VCD are inserted toward or into the vessel through the sheath, which may serve to position the various components of the VCD relative to the vessel. For example, an anchor may be inserted into the vessel through the sheath (e.g., via a carrier tube) to facilitate hemostasis or other intravascular procedures. It is often desirable for such anchors to be substantially parallel to the vessel wall. However, some sheaths have a beveled distal end. Orienting the beveled distal end substantially parallel to the vessel wall, i.e., in a bevel up position, also allows the anchor to be oriented substantially parallel to the vessel wall. However, a parallel orientation of the beveled distal end relative to the vessel wall is not desirable for inserting the sheath into the vessel, as the large surface area of the beveled distal end may contact the vessel wall, increasing the required insertion force and potentially increasing trauma on the vessel.
[0013] On the other hand, orienting the beveled distal end obliquely (at an angle) to the vessel wall, i.e., in a bevel down position, so that the tip first contacts the vessel wall, facilitates insertion. However, in this orientation, the anchor also comes out obliquely to the vessel wall in the vessel, which is undesirable. For example, if the anchor is in an angled position when the sheath is withdrawn from the vessel, it is relatively easy to inadvertently withdraw the anchor from the vessel. Manual rotation of the sheath is complicated, making it difficult to achieve the desired orientation, and also increases the risk of perforating the opposite side of the vessel wall due to unintended axial displacement.
[0014] Various embodiments of the VCD assembly described herein can provide one or more advantages including, for example: (1) facilitating insertion of the sheath into the vessel by orienting the sheath in a bevel-down position so that the tip of the beveled distal end of the sheath is inserted first through the vessel wall; (2) reducing insertion force and trauma to the vessel by allowing insertion in a bevel-down position; (3) facilitating reorientation of the beveled distal end after insertion to a bevel-up position by a simple axial movement of the dilator, which results in a reorientation of the angle of the beveled distal end without causing significant axial displacement thereof; and (4) allowing the anchor to be oriented substantially parallel to the vessel to facilitate hemostasis.
[0015] As used herein, the term "proximal end" means the end proximal to a user of the VCD assembly, and the term "distal end" means the end distal to the user of the VCD assembly and proximal to a subject undergoing a vascular closure procedure or other endovascular procedure via the VCD assembly.
[0016] 1 is a schematic block diagram of a VCD assembly 100 (hereinafter "assembly 100") according to one embodiment. Assembly 100 includes a sheath 110, a housing 130, and a dilator 150. Assembly 100 may be used to perform vascular hemostasis or other intravascular procedures (e.g., angiography, angioplasty, stent placement, etc.).
[0017] The sheath 110 is configured to be inserted through a tissue passage into a blood vessel V (e.g., a vein or an artery). In some embodiments, the sheath 110 includes a sheath body defining a channel therethrough. The channel is configured to allow passage of various hemostatic or other intravascular components. Such components may include, but are not limited to, guidewires, carrier tubes, balloon tubes, anchor tubes, needles, and the like. In some embodiments, the sheath body includes a tip and includes a beveled distal end configured to be inserted into the blood vessel V. As previously discussed, it is desirable to orient the beveled distal end obliquely (at an angle) relative to the vessel wall such that the tip of the beveled distal end contacts and is inserted through the vessel wall.
[0018] The sheath 110 may include a sheath attachment located at a proximal end of the sheath body. The sheath attachment may be disposed within the housing 130 such that the sheath attachment is rotatable relative to the housing 130 and the housing 130 constrains axial displacement of the sheath relative to the housing 130. For example, the housing 130 may include an attachment structure defined therein, the sheath attachment being disposed within the attachment structure. In some embodiments, the sheath attachment may be cylindrical and have a diameter greater than the diameter of the sheath body. In such embodiments, the attachment structure includes a cylindrical wall that extends away from a proximal wall of the housing 130 located proximate the dilator 150 toward the sheath 110. A ledge may extend radially inward from a distal edge of the cylindrical wall. The sheath mounting portion can have an axial length corresponding to the axial length of the cylindrical wall such that the mounting portion is secured between the axial distal surface of the proximal wall of the housing 130 and the proximal surface of the ledge to resist axial displacement while allowing rotation of the sheath 110 relative to the housing 130.
[0019] In some embodiments, the sheath 110 can include a sheath engagement portion configured to be engaged by the dilator 150. In some embodiments, the dilator 150 can include a dilator body and a dilator engagement portion extending from the dilator body towards the sheath 110. The dilator engagement portion is configured to engage the sheath engagement portion such that axial displacement of the dilator 150 relative to the sheath 110 rotates the sheath relative to the housing 130, while the housing is configured to constrain axial displacement of the sheath 110.
[0020] For example, the dilator 150 can be configured to move the assembly 100 between a first configuration and a second configuration. In the first configuration, the dilator body is proximate to the sheath 110, the dilator engagement portion engages the sheath engagement portion in a first position, and the tip of the beveled distal end is located, for example, in a first rotational position, where the tip of the beveled distal end is located on a side of the vessel V corresponding to a side of the vessel V on which an opening defined in the vessel V is located. Also, in the first configuration, a bisecting axis that bisects the beveled distal end and extends through the tip is oriented at an angle relative to the vessel. Thus, in the first configuration, the sheath 110 is oriented such that the beveled distal end of the sheath 110 is located proximate to the vessel V for initial entry into the vessel as the assembly 100 is axially displaced toward the vessel V. This facilitates insertion of the beveled distal end of the sheath 110 into the vessel V.
[0021] In the second configuration, the dilator engagement portion engages with the sheath engagement portion at a second position proximal to the first position, and the tip of the beveled distal end is located at a second rotational position rotationally offset from the first rotational position. Further expanding, the dilator body is moved axially away from the sheath 110 such that the dilator 150 engages and rotates the sheath 110 relative to the housing 130 such that the tip of the beveled distal end is located on the side of the vessel V opposite the side on which the opening is located. The housing 130 constrains the axial displacement of the sheath 110 relative to the housing 130. In the second configuration, the bisection axis can be substantially parallel to the vessel V, e.g., the wall of the vessel V into which the sheath 110 is inserted. As described herein, the term "substantially parallel" with respect to the bisection axis means that the bisection axis, and thus the end face of the sheath 110 formed by the beveled distal end, is oriented at an angle within a range of ±10° relative to the vessel V. The rotation may be performed after the angled distal end is inserted into the vessel through the vessel wall. The bisecting axis, whereby the angled distal end of the sheath 110 is substantially parallel to the vessel wall, facilitates orienting an anchor communicated into the vessel V through a channel defined by the sheath 110 in a desired direction, e.g., substantially parallel to the vessel wall. In some embodiments, the sheath 110 is rotatable between the first and second configurations by an angle of about 180° (e.g., in the range of 160° to 200°, inclusive), such that the second rotational position is rotationally offset by about 180° from the first rotational position.
[0022] In some embodiments, the dilator engagement portion includes one or more dilator arms (e.g., one, two, three, four or more dilator arms) extending from the dilator 150 toward the sheath 110. In such embodiments, the housing 130 defines one or more slots corresponding to the number of dilator arms. Each of the one or more dilator arms can extend through a corresponding one of the one or more slots toward the sheath engagement portion to engage the sheath engagement portion to move the assembly between the first and second configurations, for example, as described above. In other embodiments, the dilator 150 can include any other structure for engaging the sheath 110, and the dilator arms can be omitted.
[0023] The dilator engagement portion may include any suitable structure that engages with the sheath 110 to cause rotation of the sheath 110 when the dilator body is axially displaced relative to the housing 130. Such structures may include, for example, protrusions, lead screws, cams, gears, threads, etc. defined on one or more of the dilator arms. In some embodiments, the sheath engagement portion defines a groove, for example, a helical groove. For example, the sheath engagement portion may include a cylindrical structure disposed between the beveled distal end and the sheath attachment portion and may have a larger diameter than at least the sheath body, and in some embodiments, the sheath attachment portion. In some embodiments, at least a portion of the sheath engagement portion may be disposed within the housing 130. The groove may be defined on an outer surface of the sheath engagement portion. In such embodiments, the dilator engagement portion may include an engagement member (e.g., a protrusion or pin) that protrudes into the groove from a corresponding dilator arm of one or more of the dilator arms.
[0024] In the first configuration, the engagement member is located at the distal end of the groove. When the dilator 150 is moved axially away from the housing 130, the axial movement causes the engagement member to engage the groove and, e.g., slide or ride along the groove. Because the housing 130 constrains the axial displacement of the sheath 110, the engagement member, and thereby the sheath 110, is caused to rotate relative to the housing 130 until the engagement member is located at the proximal end of the groove and the assembly 100 is in the second configuration by rotation of the sheath 110, e.g., about 180 degrees.
[0025] In some embodiments, the proximal end of the groove is configured such that, once the assembly 100 is in the second configuration, axial displacement of the dilator 150 away from the housing 130 disengages the engagement member from the groove, allowing the dilator 150 to be removed from the assembly 100. For example, the proximal end of the groove may form a ramp that allows the engagement member to slide out of the groove. In other embodiments, a vertical channel may be defined on the outer surface of the sheath engagement portion from the proximal edge of the sheath engagement portion to the proximal end of the groove. Once the engagement member is at the proximal end, axial displacement of the dilator 150 away from the sheath 110 may slide the engagement member into and eventually out of the vertical channel such that the engagement member, and thus the dilator engagement portion, disengages from the sheath engagement portion, allowing the dilator 150 to be removed from the assembly 100.
[0026] In some embodiments, the dilator 150 may include an inner elongate member extending axially from the dilator body towards the sheath 110 and removably disposed through a channel defined through the sheath 110. The inner elongate member may serve to axially align the dilator 150 with respect to the sheath 110 and inhibit lateral movement of the dilator 150 with respect to the sheath 110. In such embodiments, the housing 130 may define an opening through a proximal wall of the housing located proximate to the dilator 150. The inner elongate member may be removably disposed through the opening and within the channel defined by the sheath 110. In some embodiments, the inner elongate member may define a channel through which a fluid (e.g., saline or a medicinal solution) may be inserted to dilate the blood vessel V. In some embodiments, a guidewire may be inserted through the sheath 110 into the blood vessel V, and the inner elongate member may be inserted through the sheath 110 along with the guidewire.
[0027] 2-11, various views of a VCD assembly 200 (hereinafter "assembly 200") are shown in accordance with one embodiment. Assembly 200 includes a sheath 210, a housing 230, and a dilator 250. Assembly 200 may incorporate features of assembly 100 described with reference to FIG. 1. Assembly 200 may be used to perform vascular hemostasis or other endovascular procedures (e.g., angioplasty, stent placement, etc.).
[0028] As shown in FIGS. 3 and 4a-4b, the sheath 210 includes a sheath body 212, which may be a cylindrical tubular structure defining a channel 222 therethrough. The sheath 210 is configured to be inserted through a tissue passage into a blood vessel (e.g., a blood vessel V, such as an artery or a vein). The channel 222 is configured to allow passage of various hemostatic or other intravascular components (e.g., a guidewire, a carrier tube, a balloon tube, an anchor tube, a needle, etc.) into the blood vessel. The sheath body 212 includes a beveled distal end 214 forming a tip 213. The beveled distal end 214 is configured to be inserted into the blood vessel. As previously described, it is desirable to orient the beveled distal end 214 obliquely (at an angle) relative to the wall of the blood vessel such that the tip 213 of the beveled distal end 214 contacts and is inserted through the blood vessel wall first. In some embodiments, the beveled distal end 214 is aligned with the vertical axis A of the assembly 200. L A horizontal axis perpendicular to H and a bisecting axis A bisecting the beveled distal end and extending through the tip 213. B (eg, in the range of 30° to 60°).
[0029] The sheath 210 includes a sheath attachment portion 220 located at a proximal end of the sheath body 212. The sheath attachment portion 220 can be disposed within the housing 230 such that the sheath attachment portion 220 is rotatable relative to the housing 230, and the housing 230 constrains axial displacement of the sheath 210 relative to the housing 230. The sheath body 212 can have a first diameter D1, and the sheath attachment portion 220 can have a second diameter D2 that is greater than the first diameter D1. The sheath body 212 can include a central portion 226 that is dimensioned to be located inward from the sheath engagement portion 216 and distal from the sheath attachment portion 220. As shown in FIG. 6, the central portion 226 can have a diameter greater than the first diameter D1 of the sheath body 212.
[0030] 5A-6, the housing 230 includes a housing body 232 that is open at a first end distal to the dilator 250 and includes a proximal wall 233 at a second end opposite the first end and proximal to the dilator 250 relative to the first end. The housing body 232 defines an interior volume in which an attachment structure 236 is disposed at a location indicated by arrow A. The attachment structure 236 includes a cylindrical wall 237 that extends from the proximal wall 233 toward the sheath 210. A ledge 238 extends radially inward from a distal edge of the cylindrical wall 237 such that an opening is defined at an end of the attachment structure 236 opposite the proximal wall 233. In some embodiments, the opening can have a diameter corresponding to the first diameter D1 of the sheath body 212.
[0031] 6, the sheath mount 220 is disposed within the mounting structure 236, with the sheath body 212 disposed through the opening and extending axially away from the housing 230. The sheath mount 220 may have an axial length corresponding to the axial length of the cylindrical wall 237 (i.e., corresponding to the distance between the proximal wall 233 and the ledge 238), and the diameter D2 may be greater than the inner diameter of the ledge 238, such that the sheath mount 220 is secured between the distal face of the proximal wall 233 and the proximal face of the ledge 238. In this manner, the mounting structure 236 constrains axial displacement of the sheath 210 relative to the housing 230, while allowing rotation of the sheath 210 relative to the housing 230.
[0032] The sheath 210 also includes a sheath engagement portion 216 configured to be engaged by the dilator 250, as described in further detail herein. The sheath engagement portion 216 defines a helical groove 218 having a distal end 217 and a proximal end 219. As shown in FIGS. 4A-4B, the sheath engagement portion 216 includes a cylindrical structure disposed between the beveled distal end 214 and the sheath attachment portion 220. The sheath engagement portion 216 has a third diameter D3 that is greater than the second diameter D2. At least a portion of the sheath engagement portion 216 may be disposed within the housing 230. The helical groove 218 may be defined on an outer surface of the sheath engagement portion 216.
[0033] 7, the dilator 250 can include a dilator body 252 and a dilator engagement portion 253 extending from the dilator body 252 toward the sheath 210. In some embodiments, the dilator 250 can include an inner elongate member 260 extending axially away from the dilator body 252 toward the sheath 210 and removably disposed through a channel 222 defined through the sheath 210. The inner elongate member 260 can serve to axially align the dilator 250 with respect to the sheath 210, inhibit lateral movement of the dilator 250 with respect to the sheath 210, and / or allow insertion of a dilation fluid into the blood vessel through a channel defined through the inner elongate member 260. In some embodiments, assembly 200 may include a guidewire (not shown) that is inserted through a channel 222 defined by sheath 210 into the blood vessel (e.g., prior to inserting sheath 210 into the blood vessel), and inner elongate member 260 that is guided along the guidewire through sheath 210. For example, inner elongate member 260 may be hollow such that inner elongate member 260 can be inserted into sheath 210 over the guidewire.
[0034] 5A-5B, the housing 230 forms an opening 235 through a proximal wall 233 of the housing 230 within a mounting structure 236. The inner elongate member 260 is removably positionable through the opening 235 and into a channel 222 defined by the sheath 210, and may have a length greater than a length of the sheath body 212 such that a distal end of the inner elongate member 260 protrudes through the angled distal end 214 of the sheath 210.
[0035] The dilator engagement portion 253 is configured to engage the sheath engagement portion 216 such that axial displacement of the dilator 250 relative to the housing 230 rotates the sheath 210 relative to the housing 230 while the housing 230 constrains the axial displacement of the sheath 210. The dilator engagement portion 253 includes a first dilator arm 254a and a second dilator arm 254b extending axially from opposite lateral edges of the dilator body 252 toward the sheath 210. As shown in FIGS. 5A-6, the proximal wall 233 of the housing 230 defines a first slot 234a and a second slot 234b that are configured to receive the first dilator arm 254a and the second dilator arm 254b therethrough, respectively. The first and second dilator arms 254a, 254b can extend through the first and second slots 234a, 234b toward the sheath engagement portion 216.
[0036] 3 and 7, the dilator engagement portion 253 includes an engagement member 256 (e.g., a protrusion or pin) that protrudes from the first dilator arm 254a for receipt in the helical groove 218. The engagement member 256 moves along the helical groove 218 to rotate the dilator 250 along the vertical axis A. L2. The sheath 210 is configured to rotate when displaced axially along the first dilator arm 254a (e.g., away from (or towards) the housing 230). FIGS. 3 and 7 show, among other things, that the engagement member 256 protrudes from the first dilator arm 254a (e.g., forming a male portion of the engagement assembly) and the helical groove 218 extends to the sheath engagement portion 216 (e.g., forming a female portion of the engagement assembly). In some embodiments, one or more protruding members can be provided on the sheath engagement member 216 (e.g., forming a male portion of the engagement assembly) and grooves can be provided on one or both dilator arms 254a, 254b. Expanding further, FIGS. 8A-B show the assembly 200 in a first configuration. In the first configuration, the dilator body 252 is positioned axially proximate to the housing 230, the engagement member 256 is positioned at the distal end 217 of the helical groove 218, as seen in the portion of the assembly 200 indicated by arrow B in FIG. 8B, and the angled distal end 214 is positioned in a first rotational position.
[0037] Also, as shown in FIG. 8C, the sheath body 212 has a bisecting axis A B 8C , the inner elongate member 260 is oriented at an angle to the vessel V, and the tip 213 of the angled distal end 214 of the sheath body 212 is configured to be located proximate to the vessel V to enter the vessel V first when the assembly 200 is axially displaced toward the vessel V (e.g., when the sheath 210 is inserted at an angle toward the vessel V), as shown in FIG. 8C . This facilitates insertion of the angled distal end 214 of the sheath 210 into the vessel V while in the first configuration, as shown in FIG. 8D . In some embodiments, the inner elongate member 260 is inserted into the vessel V first, for example, via an opening formed in the vessel V that is to be closed via the assembly 200 to achieve hemostasis.
[0038] To move the assembly 200 to the second configuration, the dilator 250 is moved axially away from the housing 230 in the direction indicated by arrow C in FIG. 9A. For example, a user can hold the housing 230 while pulling the dilator 250 away from the housing 230. As shown in FIGS. 9A-B, the axial displacement of the dilator 250 displaces the engagement member 256, which is in contact with the helical groove 218, axially away from the angled distal end 214 of the sheath 210, as seen in the portion of the assembly indicated by arrow E. However, because the sheath 210 is restrained from axial translation via the housing 230, the linear force that the engagement member 256 exerts on the helical groove 218 rotates the sheath engagement portion 216, and thereby the sheath 210, in the direction indicated by arrow D in FIG. 9A. This also rotates the beveled distal end 214 of the sheath 210 as shown in FIG. 9C (e.g., the beveled distal end 214 is rotated approximately 90 degrees clockwise relative to the orientation shown in FIG. 8D).
[0039] Continued axial displacement of the dilator 250 away from the housing 230 in the direction indicated by arrow C moves the assembly 200 to the second configuration shown in FIG. 10A. In the second configuration, the engagement member 256 is located at the proximal end 219 of the helical groove 218, as seen in the portion of the assembly 200 indicated by arrow F in FIG. 10B. In the second configuration, as shown in FIG. 10C, the angled distal end 214 can be rotated approximately 90° further clockwise than the orientation shown in FIG. 9C. For example, in the second configuration, the bifurcated axis A can be rotated approximately 90° further clockwise than the orientation shown in FIG. 9C without further rotation of the sheath body 212. B The sheath body 212 can be oriented such that the bisecting axis A is substantially parallel to the blood vessel and the beveled distal end 214 is or is oriented such that the bisecting axis A is substantially parallel to the blood vessel V (e.g., the proximal vessel wall). B and the relative orientation of the vessel V, e.g., the curvature of the vessel V, the vertical axis A LThe rotation of the sheath body 212 from the first configuration to the second configuration while the beveled distal end 214 is still within the vessel V can depend on factors such as the angle of the bevel, the angle of the bevel, and the angle α. The sheath body 212 is rotated from the first configuration to the second configuration while the beveled distal end 214 is still within the vessel V. In some embodiments, the sheath 210 is rotatable an angle of about 180 degrees (e.g., in the range of 160° to 200°) between the first and second configurations.
[0040] Thus, as shown in FIG. 12A, the angled distal end 214 is aligned with the bisecting axis A. B is oriented obliquely (at an angle) (e.g., not parallel) to the blood vessel and inserted into blood vessel V (e.g., through tissue passage TT as shown in FIG. 12C ) such that tip 213 first penetrates the wall of blood vessel V. After insertion (e.g., after tip 213 passes through an opening in the wall of blood vessel V), as shown in FIG. 12B , assembly 200 is moved to a second configuration via axial displacement of dilator 250, which rotates sheath 210 such that beveled distal end 214 is substantially parallel to the wall of blood vessel V. As shown in FIG. 12C , sheath 210 is aligned along bisecting axis A. B , and is thus reoriented after insertion into blood vessel V through tissue passage TT defined in tissue T so that angled distal end 214 of sheath 210 is substantially parallel to blood vessel V (e.g., the proximal wall of blood vessel V). This facilitates orienting anchor A, which is delivered through channel 222 defined by sheath 210 and into blood vessel V, in a desired orientation, e.g., substantially parallel to the wall of blood vessel V.
[0041] 11 , once the assembly 200 is in the second configuration, continued axial movement of the dilator 250 away from the housing 230 disengages the dilator 250 from the sheath engagement portion 216 such that the dilator 250 is removed from the housing 230 and ultimately from the assembly 200 as the inner elongate member 260 is withdrawn from the sheath 210. In some embodiments, the proximal end 219 of the helical groove 218 is configured such that axial displacement of the dilator 250 away from the sheath 210 disengages the engagement member 256 from the helical groove 218 once the assembly 200 is in the second configuration. For example, the proximal end 219 of the helical groove 218 may form a ramp that allows the engagement member 256 to slide out of the helical groove 218.
[0042] In other embodiments, a vertical channel may be defined on the exterior surface of the sheath engagement portion 216 from a proximal edge of the sheath engagement portion 216 located adjacent the proximal wall 233 of the housing 230 to the proximal end 219 of the helical groove 218. Once the engagement member 256 is at the proximal end 219, axial displacement of the dilator 250 away from the sheath 210 may cause the engagement member 256 to slide into the vertical channel and eventually out of the vertical channel such that the engagement member 256, and thus the dilator 250, is disengaged from the sheath engagement portion 216, allowing the dilator 250 to be removed from the assembly 200.
[0043] 13 is a schematic flow diagram of an exemplary method 300 for operating a VCD assembly (e.g., assemblies 100, 200) including a sheath (e.g., sheath 110, 210) having a sheath body (e.g., sheath body 212) defining a beveled distal end (e.g., beveled distal end 214) and a sheath attachment (e.g., sheath attachment 220) located at a proximal end of the sheath body. The assembly may also include a housing (e.g., housing 130, 230) and a dilator (e.g., dilator 150, 250) that passes through the housing and engages the sheath. Although method 300 is described with respect to assembly 200, it should be understood that operations of method 300 are similarly applicable to assembly 100 or any other assembly including components similar to those described herein.
[0044] In some embodiments, the method 300 includes inserting at least a portion of the dilator 250 into the housing 230 at 302 such that the dilator 250 engages the sheath 210 and moves the sheath 210 to a first configuration in which the tip 213 of the beveled distal end 214 is located on a side corresponding to the side of the vessel V in which the opening is located. For example, the dilator arms 254a / b can be inserted through the slots 234a / b, respectively, and the dilator 250 can be displaced axially toward the housing 230 until the engagement member 256 is inserted into and moves the helical groove 218 toward the distal end 217 of the helical groove 218, thereby rotating and moving the sheath 210 to the first configuration. In some embodiments, the dilator 250 can include an inner elongate member 260. In such embodiments, the inner elongate member 260 is first inserted through the opening 235 into the channel 222 defined by the sheath 210, and the inner elongate member 260 facilitates axial alignment of the dilator 250 with the sheath 210. As previously mentioned, the beveled distal end 214 is angled obliquely relative to the wall of the vessel V where treatment (e.g., hemostasis) is being performed such that the tip 213 is positioned proximate the wall of the vessel V.
[0045] At 304, the sheath 210, still in the first configuration, is inserted into the tissue passage TT toward the blood vessel V. As previously described, the bisecting axis A B is oriented at an angle relative to the vessel V. At 306, the tip 213 of the beveled distal end 214 is inserted into the vessel V through the wall of the vessel V (e.g., through an opening in the vessel) to a desired depth, as previously described.
[0046] At 308, the dilator 250 is axially displaced away from the housing 230 such that the dilator 250 engages the sheath 210 and rotates the sheath 210 relative to the housing 230. For example, the engagement member 256 rotates the sheath engagement portion 216 and thereby the sheath 210, about the bisecting axis A. B The sheath 210 engages the helical groove 218 which moves the sheath 210 to a second configuration that is substantially parallel to the wall of the vessel V, while the housing 230 constrains axial displacement of the sheath 210 relative to the housing 230. In some embodiments, the sheath 210 rotates approximately 180° between the first and second configurations.
[0047] At 310, the dilator 250 may be removed from the assembly 200 by continuing to axially displace the dilator 250 away from the housing 230 such that the dilator 250 disengages from the sheath 210 (e.g., by disengagement from the helical groove 218 of the engagement member 256) and is then removed from the housing 230, as previously described. At 312, an anchor (e.g., anchor A, such as a balloon or other structure disposed on a carrier tube) is inserted through the sheath 210 such that the anchor exits the angled distal end 214 and is disposed substantially parallel to the wall of the vessel V. The anchor may be used to perform vascular hemostasis or other vascular procedures.
[0048] It should be noted that the term "example" as used herein to describe various embodiments is intended to indicate that such embodiments are possible examples, representations and / or illustrations of possible embodiments (and that such terms are not necessarily intended to imply that such embodiments are particular or top-tier examples).
[0049] As used herein, the term "coupled" and similar terms means that two members are directly or indirectly coupled to one another. Such coupling may be fixed (e.g., permanent) or movable (e.g., removable or releasable). Such coupling may be achieved when the two members or the two members and an additional intermediate member are integrally formed with one another as a single body, or when the two members or the two members and an additional intermediate member are bonded to one another.
[0050] It is important to note that the configurations and arrangements of the various exemplary embodiments are merely illustrative. Although only a few embodiments are described in detail in this disclosure, those skilled in the art reviewing this disclosure will readily appreciate that many modifications (e.g., changes in size, dimensions, structure, shape and proportions of the various elements, parameter values, mounting arrangements, use of materials, colors, orientations, etc.) are possible without substantially departing from the novel teachings and advantages of the subject matter described herein. Furthermore, it should be understood that features of one embodiment disclosed herein can be combined with features of other embodiments disclosed herein, as would be understood by one skilled in the art. Other substitutions, modifications, changes and omissions can also be made in the design, operating conditions and arrangements of the various exemplary embodiments without departing from the scope of the present invention.
[0051] Although the specification contains many specific implementation details, these should not be construed as limitations on the scope of the invention or what may be claimed, but rather as descriptions of features specific to particular implementations of a particular invention. Certain features described in this specification in the context of a separate implementation may also be implemented in combination in a single implementation. Conversely, various features described in the context of a single implementation may also be implemented in multiple implementations separately or in any suitable subcombination. Furthermore, although features may be described above as operating in a particular combination and initially claimed as such, one or more features from a claimed combination may, in some cases, be deleted from the combination, and the claimed combination may be directed to a subcombination or subcombination variation.
Claims
1. A sheath comprising: a sheath body defining a channel therethrough; Sheath engagement portion, and a sheath attachment portion located at a proximal end of the sheath body; a sheath having a housing, the sheath mount being secured within the housing such that the sheath is rotatable relative to the housing and the housing constrains axial displacement of the sheath relative to the housing; An extender comprising: An expander body, and a dilator engagement portion extending from the dilator body toward the sheath, the dilator engagement portion is configured to engage the sheath engagement portion such that axial displacement of the dilator relative to the sheath rotates the sheath relative to the housing, and the housing is configured to constrain axial displacement of the sheath during rotation. a dilator; Vascular closure device assembly.
2. the sheath body has a tip and a beveled distal end configured to be inserted into a blood vessel; The assembly is movable between (i) a first configuration in which the dilator engagement portion engages the sheath engagement portion at a first position and the tip of the angled distal end is at a first rotational position, and (ii) a second configuration in which the dilator engagement portion engages the sheath engagement portion at a second position proximal to the first position and the tip of the angled distal end is at a second rotational position that is rotationally offset from the first rotational position. The vascular closure device assembly of claim 1.
3. the second rotational position is rotationally offset from the first rotational position by approximately 180 degrees. The vascular closure device assembly of claim 2.
4. the dilator engagement portion has one or more dilator arms extending from the dilator body toward the sheath; The vascular closure device assembly of claim 2.
5. the housing defines one or more slots; each of the one or more dilator arms extends through a corresponding one of the one or more slots toward the sheath engagement portion; The vascular closure device assembly of claim 4.
6. the sheath engagement portion defines a helical groove; the dilator engagement portion having an engagement member protruding from a corresponding one of the one or more dilator arms into the helical groove. The vascular closure device assembly of claim 4.
7. The diameter of the sheath engagement portion is larger than the diameter of the sheath body. The vascular closure device assembly of claim 6.
8. In the first configuration, the engagement member is located at a distal end of the spiral groove; In the second configuration, the engagement member is located at a proximal end of the helical groove. The vascular closure device assembly of claim 6.
9. the proximal end of the helical groove is configured such that when the assembly is in the second configuration, proximal displacement of the dilator causes the engagement member to disengage from the helical groove such that the dilator can be removed from the assembly. The vascular closure device assembly of claim 7.
10. The expander further comprises: an inner elongate member extending axially away from the dilator body toward the sheath and removably disposed through the channel defined through the sheath; The vascular closure device assembly of claim 1.
11. the housing defines an opening through a proximal wall of the housing, the inner elongate member being removably disposed through the opening and within the channel defined by the sheath. The vascular closure device assembly of claim 10.
12. the housing includes a mounting structure defined therein; the sheath attachment portion is disposed within the attachment structure; The vascular closure device assembly of claim 1.
13. the sheath attachment portion is cylindrical and has a diameter greater than a diameter of the sheath body; The mounting structure comprises: a cylindrical wall extending away from a proximal wall of the housing adjacent the dilator toward the sheath; a ledge extending radially inward from a distal edge of the cylindrical wall; the sheath mount has an axial length corresponding to an axial length of the cylindrical wall such that the sheath mount is secured between a distal surface of the proximal wall of the housing and a proximal surface of the ledge to restrict axial displacement while allowing rotation of the sheath relative to the housing. The vascular closure device assembly of claim 12.